{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:37:36Z","timestamp":1785818256433,"version":"3.56.0"},"reference-count":87,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1644,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.2040-1124.2011.00106.x","type":"journal-article","created":{"date-parts":[[2011,3,4]],"date-time":"2011-03-04T08:00:18Z","timestamp":1299225618000},"page":"158-169","source":"Crossref","is-referenced-by-count":79,"title":["Genetics and pathophysiology of neonatal diabetes mellitus"],"prefix":"10.1111","volume":"2","author":[{"given":"Rochelle N","family":"Naylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siri Atma W","family":"Greeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme I","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis H","family":"Philipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,3,2]]},"reference":[{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra0808284","article-title":"Genetics of type 1A diabetes","volume":"360","author":"Concannon","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng.609","article-title":"Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis","volume":"42","author":"Voight","year":"2010","journal-title":"Nat Genet"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ncpendmet0778","article-title":"Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes","volume":"4","author":"Murphy","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB4|cit4","first-page":"389","volume-title":"Pancreatic Beta Cell in Health and Disease","author":"Edghill","year":"2008"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1399-5448.2008.00433.x","article-title":"Diagnosis and treatment of neonatal diabetes: an United States experience","volume":"9","author":"Stoy","year":"2008","journal-title":"Pediatr Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tem.2010.03.004","article-title":"Neonatal diabetes mellitus: a model for personalized medicine","volume":"21","author":"Greeley","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"F39","DOI":"10.1136\/fn.76.1.F39","article-title":"Aetiology and genetic basis of neonatal diabetes","volume":"76","author":"Shield","year":"1997","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1399-0039.2000.560303.x","article-title":"HLA-DRB 1 and DQB1 genotypes in patients with insulin-dependent neonatal diabetes mellitus. A study of 13 cases","volume":"56","author":"Marquis","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00125-002-0837-2","article-title":"Permanent diabetes mellitus in the first year of life","volume":"45","author":"Iafusco","year":"2002","journal-title":"Diabetologia"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/db06-0094","article-title":"HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months","volume":"55","author":"Edghill","year":"2006","journal-title":"Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.diabres.2009.07.011","article-title":"Neonatal diabetes in a child positive for islet cell antibodies at onset and Kir6.2 activating mutation","volume":"86","author":"Gach","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2337\/dc08-1188","article-title":"Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes","volume":"32","author":"Rubio-Cabezas","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"F341","DOI":"10.1136\/adc.2003.030502","article-title":"An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission","volume":"89","author":"Shield","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2337\/diabetes.49.8.1359","article-title":"Transient neonatal diabetes mellitus: widening our understanding of the aetiopathogenesis of diabetes","volume":"49","author":"Temple","year":"2000","journal-title":"Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ng0295-110","article-title":"An imprinted gene(s) for diabetes?","volume":"9","author":"Temple","year":"1995","journal-title":"Nat Genet"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/hmg\/9.3.453","article-title":"The cell cycle control gene ZAC\/PLAG1 is imprinted-a strong candidate gene for transient neonatal diabetes","volume":"9","author":"Kamiya","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/jmg.39.12.872","article-title":"Transient neonatal diabetes, a disorder of imprinting","volume":"39","author":"Temple","year":"2002","journal-title":"J Med Genet"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"11975","DOI":"10.1158\/0008-5472.CAN-06-1529","article-title":"Peroxisome proliferator-activated receptor gamma is a Zac target gene mediating Zac antiproliferation","volume":"66","author":"Barz","year":"2006","journal-title":"Cancer Res"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/hmg\/10.14.1475","article-title":"A conserved imprinting control region at the HYMAI\/ZAC domain is implicated in transient neonatal diabetes mellitus","volume":"10","author":"Arima","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1172\/JCI200419876","article-title":"Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDM","volume":"114","author":"Ma","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2337\/db07-0043","article-title":"Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood","volume":"56","author":"Flanagan","year":"2007","journal-title":"Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/jmg.2005.032854","article-title":"Mutations in hepatocyte nuclear factor-1beta and their related phenotypes","volume":"43","author":"Edghill","year":"2006","journal-title":"J Med Genet"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1464-5491.2006.01999.x","article-title":"Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development","volume":"23","author":"Edghill","year":"2006","journal-title":"Diabet Med"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1210\/jc.2003-031828","article-title":"Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: Phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1beta gene due to germline mosaicism","volume":"89","author":"Yorifuji","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1210\/jc.2005-1156","article-title":"Letter Re: neonatal diabetes mellitus and mutation in the HNF-1beta gene","volume":"90","author":"D\u2019Amato","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1073\/pnas.0910533107","article-title":"Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis","volume":"107","author":"Garin","year":"2010","journal-title":"PNAS"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa032922","article-title":"Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes","volume":"350","author":"Gloyn","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMoa055068","article-title":"Activating mutations in the ABCC8 gene in neonatal diabetes mellitus","volume":"355","author":"Babenko","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/sj.ejhg.5201629","article-title":"KCNJ11 activating mutations are associated with developmental delay, epilepsy, and neonatal diabetes syndrome and other neurological features","volume":"14","author":"Gloyn","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1126\/science.1186146","article-title":"Muscle dysfunction caused by a KATP channel mutation in neonatal diabetes in neuronal in origin","volume":"329","author":"Clark","year":"2010","journal-title":"Science"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1086\/519174","article-title":"Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects","volume":"81","author":"Ellard","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.1073\/pnas.0707291104","article-title":"Insulin gene mutations as a cause of permanent neonatal diabetes","volume":"104","author":"St\u00f8y","year":"2007","journal-title":"PNAS"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2337\/db07-1358","article-title":"Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) study group","volume":"57","author":"Polak","year":"2008","journal-title":"Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2337\/db07-1405","article-title":"Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood","volume":"57","author":"Edghill","year":"2008","journal-title":"Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/db07-1467","article-title":"Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes","volume":"57","author":"Molven","year":"2008","journal-title":"Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2337\/db09-1091","article-title":"Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention","volume":"59","author":"Meur","year":"2010","journal-title":"Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1152\/ajpendo.00592.2009","article-title":"In vitro processing and secretion of mutant insulin proteins that cause permanent neonatal diabetes","volume":"298","author":"Rajan","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.bbrc.2009.12.090","article-title":"Mutant proinsulin proteins associated with neonatal diabetes are retained in the endoplasmic reticulum and not efficiently secreted","volume":"391","author":"Park","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB39|cit39","first-page":"2148","article-title":"Seven mutations in the human insulin gene linked to permanent neonatal\/infancy-onset diabetes mellitus","volume":"118","author":"Colombo","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1074\/jbc.M109.038042","article-title":"Misfolded proinsulin affects bystander proinsulin in neonatal diabetes","volume":"285","author":"Hodish","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1096\/fj.03-1210fje","article-title":"Misfolded proinsulin accumulates in expanded pre-Golgi intermediates and endoplasmic reticulum subdomains in pancreatic beta cells of Akita mice","volume":"18","author":"Zuber","year":"2004","journal-title":"FASEB J"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2337\/diabetes.52.2.409","article-title":"Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse","volume":"52","author":"Izumi","year":"2003","journal-title":"Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2337\/db06-0658","article-title":"Dominant-negative effects of a novel mutated Ins2 allele causes early-onset diabetes and severe beta-cell loss in Munich Ins2C95S mutant mice","volume":"56","author":"Herbach","year":"2007","journal-title":"Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/eje.0.1380233","article-title":"Genetic, metabolic and clinical characteristics of maturity onset diabetes of the young","volume":"138","author":"Velho","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJM200105243442104","article-title":"Permanent neonatal diabetes mellitus due to glucokinase deficiency: an inborn error of the glucose\/insulin signaling pathway","volume":"344","author":"Njolstad","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jpeds.2007.12.037","article-title":"Permanent neonatal diabetes mellitus caused by a novel homozygous (T168A) glucokinase (GCK) mutation; initial response to oral sulphonylurea therapy","volume":"153","author":"Turkkahraman","year":"2008","journal-title":"J Pediatr"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.2174\/092986709789177993","article-title":"Medicinal chemistry approaches for glucokinase activation to treat type 2 diabetes","volume":"16","author":"Pal","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1021\/jm100039a","article-title":"Discovery, structure-activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675)","volume":"53","author":"Haynes","year":"2010","journal-title":"J Med Chem"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejphar.2010.04.054","article-title":"A small-molecule glucokinase activator lowers blood glucose in the sulfonylurea-desensitized rat","volume":"640","author":"Ohyama","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1399-5448.2006.00217.x","article-title":"ISPAD Clinical Practice Consensus Guidelines 2006-2007. The diagnosis and management of monogenic diabetes in children","volume":"7","author":"Hattersley","year":"2006","journal-title":"Pediatr Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.2337\/db10-0011","article-title":"Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities","volume":"59","author":"Rubio-Cabezas","year":"2010","journal-title":"Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1097-2765(01)00264-7","article-title":"Diabetes mellitus and exocrine pancreatic dysfunction in perk \u2212\/\u2212 mice reveals a role for translational control in secretory cell survival","volume":"7","author":"Harding","year":"2001","journal-title":"Mol Cell"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/MCB.22.11.3864-3874.2002","article-title":"The PERK eukaryotic initiation factor 2\u03b1 kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas","volume":"22","author":"Zhang","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1210\/jc.2009-1137","article-title":"Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families","volume":"94","author":"Rubio-Cabezas","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1399-5448.2009.00518.x","article-title":"Wolfram syndrome: important implications for pediatricians and pediatric endocrinologists","volume":"11","author":"Kumar","year":"2010","journal-title":"Pediatr Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1515\/JPEM.2002.15.9.1461","article-title":"Pancreatic Duodenal Homeobox (PDX-1) in health and disease","volume":"15","author":"Melloul","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1399-5448.2009.00526.x","article-title":"Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF-1 Pro63fsX60 mutation","volume":"10","author":"Thomas","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2337\/db09-1284","article-title":"A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency","volume":"59","author":"Nicolino","year":"2010","journal-title":"Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/ng1475","article-title":"Mutations in PTF1A cause pancreatic and cerebellar agenesis","volume":"36","author":"Sellick","year":"2004","journal-title":"Nat Genet"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB60|cit60","first-page":"147","article-title":"A Turkish newborn infant with cerebellar agenesis\/neonatal diabetes mellitus and PTF1A mutation","volume":"20","author":"Tutak","year":"2009","journal-title":"Genet Couns"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.2337\/db07-1558","article-title":"Reduction of Ptf1a gene dosage causes pancreatic hypoplasia and diabetes in mice","volume":"57","author":"Fukuda","year":"2008","journal-title":"Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.febslet.2009.05.039","article-title":"A murine model of neonatal diabetes mellitus in Glis3-deficient mice","volume":"583","author":"Watanabe","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ng1802","article-title":"Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism","volume":"38","author":"Sen\u00e9e","year":"2006","journal-title":"Nat Genet"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1101\/gad.9.8.1009","article-title":"Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor","volume":"9","author":"Naya","year":"1995","journal-title":"Genes Dev"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1399-5448.2007.00365.x","article-title":"Neonatal diabetes mellitus because of pancreatic agenesis with dysmorphic features and recurrent bacterial infections","volume":"9","author":"Taha","year":"2008","journal-title":"Pediatr Diabetes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"e1541","DOI":"10.1542\/peds.2007-3543","article-title":"Neonatal and late-onset diabetes mellitus caused by failure of pancreatic development: report of 4 more cases and a review of the literature","volume":"121","author":"Chen","year":"2008","journal-title":"Pediatrics"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ajmg.a.33194","article-title":"Pancreatic hypoplasia presenting with neonatal diabetes mellitus in association with congenital heart defect and developmental delay","volume":"152A","author":"Balasubramanian","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/dc07-1785","article-title":"Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations","volume":"31","author":"Rafiq","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2006-2490","article-title":"Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers","volume":"92","author":"Stanik","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1210\/jc.2007-0486","article-title":"Molecular basis of neonatal diabetes in Japanese patients","volume":"92","author":"Suzuki","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1515\/JPEM.2008.21.9.895","article-title":"Familial permanent neonatal diabetes with KCNJ11 mutation and the response to glyburide therapy - a three-year follow-up","volume":"21","author":"Begum-Hasan","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1464-5491.2007.02373.x","article-title":"Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation","volume":"25","author":"Slingerland","year":"2008","journal-title":"Diabet Med"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1210\/jc.2007-1826","article-title":"The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy","volume":"93","author":"Koster","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1464-5491.2007.02228.x","article-title":"Sulphonylurea treatment does not improve psychomotor development in children with KCNJ11 mutations causing permanent neonatal diabetes mellitus accompanied by developmental delay and epilepsy (DEND syndrome)","volume":"24","author":"Sumnik","year":"2007","journal-title":"Diabet Med"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ncpneuro0640","article-title":"Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11","volume":"3","author":"Mlynarski","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"758","DOI":"10.2337\/diacare.28.3.758","article-title":"High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation","volume":"28","author":"Codner","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.2337\/dc09-0280","article-title":"Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect","volume":"32","author":"Kumaraguru","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MED.0b013e328334f158","article-title":"Update in neonatal diabetes","volume":"17","author":"Greeley","year":"2010","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1464-5491.2009.02704.x","article-title":"Glibenclamide treatment in relapsed transient neonatal diabetes as a result of a KCNJ11 activating mutation (N48D)","volume":"26","author":"Mart\u00edn-Fr\u00edas","year":"2009","journal-title":"Diabet Med"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1210\/jc.2004-0568","article-title":"Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the \u03b2-cell potassium adenosine triphosphate channel","volume":"89","author":"Gloyn","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/B978-0-12-374430-2.00002-X","volume-title":"Genetic Diagnosis of Endocrine Disorders","author":"Philipson","year":"2010"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB84|cit84","doi-asserted-by":"crossref","DOI":"10.2337\/dc10-1616","article-title":"The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes","author":"Greeley","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1464-5491.2010.02965.x","article-title":"Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV)","volume":"27","author":"Grulich-Henn","year":"2010","journal-title":"Diabet Med"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.2337\/dc06-2440","article-title":"Islet-specific antibody seroconversion in patients with long duration of permananet neonatal diabetes caused by mutations in the KCNJ11 gene","volume":"30","author":"Gach","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1111\/j.2040-1124.2011.00106.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/pdi.1385","article-title":"Glibenclamide controls ketosis-prone diabetes in a 38-year-old woman with Kir6.2 mutation","volume":"26","author":"Jose","year":"2009","journal-title":"Pract Diab Int"}],"container-title":["Journal of Diabetes Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2040-1124.2011.00106.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.2040-1124.2011.00106.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T20:33:54Z","timestamp":1625603634000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.2040-1124.2011.00106.x"}},"subtitle":["Neonatal diabetes mellitus"],"short-title":[],"issued":{"date-parts":[[2011,3,2]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.2040-1124.2011.00106.x","relation":{},"ISSN":["2040-1116"],"issn-type":[{"value":"2040-1116","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3,2]]}}}